SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-299252
Filing Date
2018-10-15
Accepted
2018-10-15 16:31:06
Documents
3
Period of Report
2018-10-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d638594d8k.htm 8-K 19899
2 EXHIBIT 99.1 d638594dex991.htm EX-99.1 9885
3 GRAPHIC g638594g92a24.jpg GRAPHIC 11783
  Complete submission text file 0001193125-18-299252.txt   47850
Mailing Address 30721 RUSSELL RANCH ROAD SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30721 RUSSELL RANCH ROAD SUITE 140 WESTLAKE VILLAGE CA 91362 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35560 | Film No.: 181122534
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences